|
|
 |
|
Viewing report
|
|
|
|
Chinese Markets for Blood Disease Drugs
AMID Co., June 2009, Pages: 271
Chinas demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines Chinas economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through to 2013 and 2018 are presented. Major producers in China are profiled.
Customers who bought this item also bought
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth
Chinese Markets for Leukemia Treatment Drugs
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
Drug Delivery in Cancer - Technologies, Markets and Companies
Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Chinese Markets for Kidney Cancer Treatment Drugs
Chinese Markets for Skin Cancer Treatment Drugs
Chinese Markets for Sleep Disorder Treatment Drugs
|
|
|
|
